Biogen

Biogen

Biotechnology Research

Cambridge, MA 997,568 followers

About us

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.

Website
http://www.biogen.com
Industry
Biotechnology Research
Company size
5,001-10,000 employees
Headquarters
Cambridge, MA
Type
Public Company

Locations

Employees at Biogen

Updates

  • View organization page for Biogen, graphic

    997,568 followers

    From Boston to São Paulo to Tokyo to Zurich, ReachOUT, Biogen’s LGBTQ+ ERG, and our colleagues brought Pride Month to life at work and in their communities around the world. Biogen aspires for every employee to feel a sense of belonging, and we recognize celebrations like these help to foster connection and understanding.     Learn how we promote inclusion around the world: https://ow.ly/kjxi50SrHn9    #PrideMonth | #LGBTQ | #TeamBiogen 

  • View organization page for Biogen, graphic

    997,568 followers

    Join us at the European Academy of Neurology (EAN) for a pivotal discussion driving the future of Alzheimer’s disease care.   This session will delve into the critical journey of Alzheimer’s disease biomarkers, bridging research with clinical applications. Attendees will gain insights from leading experts and connect with professionals dedicated to transforming Alzheimer’s treatment.   If you are registered to EAN, you can watch the live session online: https://ow.ly/YmyU50SqTP2   #EAN2024 | #AlzheimersResearch | #HCPs

  • View organization page for Biogen, graphic

    997,568 followers

    We are proud to share that our Spinal Muscular Atrophy (SMA) awareness campaign, "Not a Lonely Journey", won the Bronze prize at The Pharma Lions awards in Cannes. "Not a Lonely Journey" is a travel guide featuring adventures of people with SMA along with tips and advice on how to explore the world while living with SMA.    Learn more about the campaign: https://lnkd.in/g37rQQN4   #SpinalMuscularAtrophy | #SMA

    • No alternative text description for this image
  • View organization page for Biogen, graphic

    997,568 followers

    We’re attending the European Academy of Neurology (EAN) Congress 2024 in Helsinki, Finland, from June 29th until July 2nd.   Our commitment to advancing neurological research and patient care continues as we present our latest innovations and findings.   This year, we will highlight our work in Friedreich ataxia and Alzheimer's disease, as well as our increased dedication to rare diseases. Learn more: https://ow.ly/TbtX50Spw1i   #EAN2024 | #Biogen | #Neurology | #Innovation | #Healthcare | #HCPs

  • View organization page for Biogen, graphic

    997,568 followers

    Promoting employee wellness not only reflects Biogen’s values, but also can contribute to business success. This World Wellbeing Week, we bring more attention to Biogen’s benefits that span four dimensions of wellness: physical, financial, social and emotional.   Learn more about our commitment to employee wellness for employees and their families: https://ow.ly/S2Hu50SpqVc   #WorldWellbeingWeek | #EmployeeEngagement | #TeamBiogen

  • View organization page for Biogen, graphic

    997,568 followers

    Physio all: cuidado de excelência para AME 💙 Este fim de semana, tivemos um marco importante para a comunidade de Atrofia Muscular Espinhal (AME), com o inovador e inspirador evento promovido pela Biogen, o #Physioall. Realizado em São Paulo, o encontro único reuniu dezenas de especialistas de todos os cantos do Brasil, incluindo fisioterapeutas especializados em segmentos respiratórios e motores, fonoaudiólogos, entre outros, com o objetivo de aprimorar a abordagem para o cuidado da #AME. Por isso, buscando sempre o avanço e o pioneirismo científico, nosso time levou para o encontro a importância da fisioterapia respiratória, motora e fonoaudiologia para a melhora da qualidade de vida dos pacientes. Paula Yurie Tanaka, TA Leader para AME e ELA na Biogen, falou um pouco sobre esse momento. “O Physio all foi um sucesso, o que não seria possível sem o apoio do time de eventos e a coordenação da Sarah Bernardes, Medical Science Liaison na Biogen e que também é fisioterapeuta, além do apoio incondicional da nossa diretora médica Tatiana Branco. Tópicos importantes como função bulbar, escalas bulbares, além da fisioterapia respiratória em AME, chamaram a atenção dos participantes que tiveram a oportunidade de interagir com profissionais reconhecidos nessas áreas, o que ficou evidente pela grande quantidade de perguntas da plateia, gerando discussões científicas extremamente produtivas.” Agradecemos ao nosso incrível time, que segue, por meio de iniciativas como essa, atuando com muita excelência e ajudando a transformar a vida de pacientes e familiares para melhor, e a todos os participantes por seu compromisso contínuo e paixão em fazer a diferença para a comunidade AME. #Biogen #BiogenBrasil #ParaTodosVerem  Há um conjunto de fotos que trazem dezenas de pessoas reunidas no local do evento do Physio all. As pessoas estão de pé, sentadas e agachadas e posam para as fotos.

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Biogen, graphic

    997,568 followers

    Biogen is excited to announce that the European Commission (EC) has granted marketing authorization for a proposed biosimilar for treatment of immune-mediated inflammatory diseases. This approval offers European patients with several inflammatory and immune-mediated inflammatory diseases access to an additional affordable biologic treatment option with comparable safety and efficacy to the approved reference product. Read more in the news release: https://ow.ly/Ox7y50SofzX

Affiliated pages

Similar pages

Browse jobs

Stock

BIIB

NASDAQ

20 minutes delay

$231.82

3.1 (1.355%)

Open
229.5
Low
227.73
High
235.49

Data from Refinitiv

See more info on Bing

Funding

Biogen 1 total round

Last Round

Post IPO debt

US$ 1.5B

Investors

JP Morgan
See more info on crunchbase